Pelago Bioscience AB

Pelago Bioscience AB is a leading biotechnology research company dedicated to accelerating drug discovery through innovative solutions. Utilizing the proprietary CETSA® (Cellular Thermal Shift Assay) technology, Pelago Bioscience provides actionable, biologically relevant insights at the pre-clinical stage. The company's commitment to certainty in biological relevance ensures that observations in cells translate effectively to patient outcomes.

Located at Scheeles väg 1, Solna, 17165, SE, Pelago Bioscience offers a comprehensive suite of services designed to deliver fast and early confidence in drug-target interactions. With a focus on compound prioritization and predicting future research steps, Pelago Bioscience helps reduce project costs and streamline the drug development process. The company operates as a dedicated partner, designing fit-for-purpose studies that align with clients' goals.

Pelago Bioscience AB's data supports critical decision-making, enabling researchers to move forward with confidence. Information on Pelago Bioscience is being continuously updated to reflect the company's advancements. We invite the management of Pelago Bioscience AB to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.